Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

6.16
Delayed Data
As of Apr 28
 -0.06 / -0.96%
Today’s Change
5.14
Today|||52-Week Range
14.76
-29.36%
Year-to-Date

Today’s Trading

Previous close6.22
Today’s open6.17
Day’s range6.03 - 6.42
Volume407,618
Average volume (3 months)785,563
Market cap$328.3M
Dividend yield--
Data as of 04/28/2016

Growth & Valuation

Earnings growth (last year)+16.28%
Earnings growth (this year)-28.17%
Earnings growth (next 5 years)--
Revenue growth (last year)+170.69%
P/E ratioNM
Price/Sales21.60
Price/Book2.64

Competitors

 Today’s
change
Today’s
% change
MYOKMyoKardia Inc-0.32-2.56%
KPTIKaryopharm Therapeut...-0.04-0.42%
CNCEConcert Pharmaceutic...+0.22+1.56%
AKBAAkebia Therapeutics ...+0.07+0.75%
Data as of 04/28/2016

Financials

Next reporting dateMay 3, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$20.8M
Annual profit (last year)-$55.7M
Net profit margin-268.55%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
COO, Principal Financial &
Accounting Officer
Joseph P. Hagan
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs